Introduction
When faced with cases of suspected non-accidental injury in children, the criminal justice and child welfare systems must determine whether the child is being abused or is suffering from abnormal bruising or bleeding due to a haematological disorder, or both. These decisions can be extremely difficult to make, not least because there exists a wide inter-individual variation in the degree of bruising and bleeding observed following defined episodes of trauma [1] . Thus, physicians are frequently called upon by courts of law to provide expert witness testimony so that an accurate clinical picture of the child's injuries can be considered [2] .
Children with easy bruising or bleeding are frequently referred to a haematologist for evaluation. It is the haematologist's responsibility to determine whether the injuries are consistent with the child's age, past and family history, development, and level of activity. If not, then child protection issues must be considered [3] . Before the courts can establish a case of abuse, however, it is important that the child's haemostatic function is appropriately assessed. A severe bleeding disorder may result in extensive bruising or bleeding following relatively minor trauma, and may occasionally produce spontaneous bleeding, leading to erroneous allegations of intentional injury if the coagulation deficit remains undiagnosed. The court will also usually need to know whether or not a minor bleeding tendency [such as von Willebrand's disease (vWD)] is present, as this could lead to bruising or more prolonged or severe injury following lesser trauma. It is usually not sufficient just to rule out severe defects [4] .
When giving evidence as an expert witness, it is the haematologist's duty to state that a child does or does not have a bleeding or bruising tendency; the responsibility for making a final diagnosis of abuse, accidental injury, or haematological dysfunction always lies with the court.
The present article will discuss the methods used and the problems encountered by today's haematologists when attempting to verify or exclude coagulation disorders in potential cases of non-accidental injury.
Bruising and bleeding in children: abuse or haematological dysfunction?
The initial diagnostic approach to easy bruising and bleeding must include a careful physical examination and analysis of the family history, including a history of consanguinity [5, 6] . The physical examination should evaluate evidence of bleeding or bruising and determine whether systemic illness exists, whereas the family history may establish a degree of clinical suspicion for a bleeding disorder and provides clues towards a specific diagnosis [6] . A history of bleeding following dental or surgical procedures should be sought during examination of the family history, and menorrhagia in female family members may be indicative of disorders such as vWD [7, 8] or factor XI deficiency [9] [10] [11] [12] . Many of the severe coagulation factor deficiencies, such as factor V, factor X or factor XIII deficiency, are autosomal recessive and much more common in consanguineous partnerships. Despite the importance of a detailed family history, it often gets forgotten by hospital staff on admission and should then be fully documented by the haematologist.
A drug history should be taken, as certain medications-particularly non-steroidal anti-inflammatory drugs-can cause acquired platelet dysfunction. Vitamin K deficiency must be considered in small infants with any evidence of bruising or bleeding; both these symptoms are abnormal in babies younger than the age of 6 months. A lack of vitamin K therapy in breast-fed neonates can lead to classical late haemorrhagic disease of the newborn [13, 14] , which may present up to 6 weeks of age with intracranial haemorrhage that often follows 'herald' bleeds. Maternal anticonvulsants predispose to early haemorrhagic disease [15] .
The proposed cause of injury should be considered in a child with easy bruising/bleeding, and it must be determined whether the injury is consistent with the child's age, history, and level of activity [3] . Furthermore, the age of onset of bruising/bleeding is an important consideration. For instance, bruising in babies younger than the age of 1 year is rare [16] , and such findings in young infants may therefore point towards either non-accidental injury [3] or a coagulation disorder. The presence of other co-existent injuries, such as fractures, make the former more likely than the latter; hence the need for a full physical and radiographic examination prior to referral for a haemostatic work-up. It must be noted that examination of bruise appearance does not allow assessment of bruise age with any degree of accuracy [2] .
First-line tests for the assessment of coagulation
There is no current consensus regarding the exact series of investigations indicated to exclude a haemostatic disorder in infants and children with easy bruising/bleeding. There are, however, several tests and procedures that are routinely used by haematologists in these situations.
The full blood count (FBC) and film should be examined in all children [17, 18] as well as carrying out a baseline coagulation screen [19] . A prolonged activated partial thromboplastin time (aPTT) should be complemented with a mixing study with normal plasma in order to differentiate between a factor deficiency and a circulating inhibitor. If correction of the aPTT is observed in a 50:50 mix of patient and control plasma, a factor deficiency may be present. In contrast, incomplete or minimal correction suggests the presence of an inhibitor, such as a lupus anticoagulant [20] .
A prolonged thrombin time may be caused by the presence of heparin in a blood sample (which can be confirmed by a normal reptilase time or following protamine correction), the presence of hereditary or acquired fibrinogen abnormalities (dysfibrinogenaemia or hypofibrinogenaemia) [19] , or elevated fibrin/fibrinogen degradation products as seen in disseminated intravascular coagulation. A functional Clauss fibrinogen assay should be performed. Finally, biochemical screens are often performed in children with easy bruising or bleeding, with particular emphasis on detecting potential abnormalities in hepatic and renal function. Such impairments can lead to platelet dysfunction, dysfibrinogenaemia, and other defects [21] [22] [23] . It is not appropriate to provide herein a comprehensive list of abnormalities that can be detected using blood count and film examination; it is sufficient to emphasize that it is particularly important to look for leukaemic blasts when a low platelet count is found. In these circumstances, it is also important to look for other abnormalities, such as giant platelets [Bernard-Soulier syndrome (BSS) or other macro-thrombocytopaenias with high mean platelet volume] [24] . Screening for other well-known causes of thrombocytopenia (such as idiopathic thrombocytopenic purpura, Fanconi anaemia [25] , aplastic anaemia, and druginduced thrombocytopenia) should clearly be carried out when low platelet counts persist.
If the results of the coagulation screen are normal, then the presence of severe deficiencies of fibrinogen and factor II, factor V, factor VII, factor VIII, factor IX, factor X, or factor XI can be ruled out. An abnormal coagulation screen can be due to a number of reasons, as presented more fully in Table 1 . Rarely, a transient acquired inhibitor of coagulation can develop, usually as a result of a viral infection-an example of this is an acquired hypoprothrombinaemia in association with a viral triggered antiphospholipid antibody [26, 27] .
When evaluating coagulation screens and establishing whether children have normal or abnormal values for certain tests, it is important to be aware that physiological differences exist between the coagulation systems of children and adults. For instance, the levels of several clotting factors are considerably lower in healthy full-term infants at birth when compared with adults (Table 2) , with premature infants showing even more pronounced reductions. In general, the postnatal maturation of the coagulation system towards adult status is accelerated in premature infants when compared with full-term babies, and by 6 months of age most components of the coagulation system in premature infants begin to approach adult values [28] . Nonetheless, when conducting assessments of coagulation in full-term and premature babies younger than 1 year of age, it must be remembered that normal ranges of tests such as the aPTT and prothrombin time will also differ from those observed in adult patients (Table 3 ) [28] . It is therefore crucial that gestational or postnatal age is taken into consideration when interpreting coagulation results. International Normalized Ratio values and aPTT ratios should be used only for anticoagulant monitoring, and it must be remembered that the control value used in these ratios is derived from pooled normal adult plasma.
Coagulation screens cannot detect all haemostatic disorders
Some conditions that produce a bleeding or bruising diathesis are associated with a normal FBC and coagulation screen. Such conditions include milder forms of haemophilia A or haemophilia B and vWD, along with deficiencies of factor XI, factor VII, AE2-antiplasmin [29] , plasminogen activator inhibitor-1 [30] , and factor XIII [31] [32] [33] . Finally, collagen disorders may also produce normal FBC and coagulation screens [34] .
von Willebrand's disease vWD is now recognized as the most common inherited bleeding disorder with a prevalence of 1:100-1:1000 [35, 36] . It is caused by quantitative or qualitative defects of von Willebrand's factor (vWF) [37] . Prior to puberty, the milder forms typically present with epistaxis or easy bruising, although the condition is characterized by a heterogeneous and variable clinical presentation. Type 1 vWD is associated with a mild bleeding phenotype and, as with other minor bleeding disorders, it is important for the court to be made aware that patients may be predisposed to more severe or prolonged bleeding following significant injury. Type 2 vWD presents with a variable bleeding tendency, but type 3 is associated with a severe haemorrhagic diathesis from infancy [19] .
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited. The diagnosis of vWD requires a detailed patient and family history, and many patients are first diagnosed following prolonged bleeding after dental extraction or surgery [19] . The moderate and severe forms of the condition, namely the different subtypes of type 2 and type 3 [19] , are relatively easy to diagnose; however, definitive diagnosis of mild (type 1) vWD remains a problem [4] . These diagnostic problems are exacerbated by the fact that factors outside the vWF gene (e.g. the blood group of the affected individual) also influence vWF levels. In addition, children and infants have lower levels of vWF than adults [38] , further complicating the recognition of vWD in this population. The development of effective molecular tests may help to increase the accuracy of vWD diagnosis in children, but until such tests are developed the detection of the disorder remains a significant challenge for haematologists.
Factor XI and factor VII deficiencies
Factor XI deficiency is a rare bleeding disorder characterized by autosomal inheritance and a variable clinical phenotype [12] . The disorder is highly prevalent among Jews of Ashkenazi (European) origin, and occurs only sporadically in other populations [39] . Both heterozygous and homozygous individuals may present with a bleeding diathesis, although there exists no clear relationship between factor XI level and bleeding tendency [9, 11] . Furthermore, the haemorrhagic tendency may not be consistent within families [10] . Heterozygotes may have levels between 50 and 70 IU/dl; the routine coagulation screen would not normally detect levels such as these, and so a factor XI assay should be performed if there is a personal or family history of bleeding or bruising.
Factor VII deficiency can cause significant bleeding when inherited as a homozygous characteristic, but heterozygotes can also have a mild bleeding/bruising tendency [40] . The severe phenotypes may present in the neonatal period with severe bleeding and intracerebral haemorrhage, and such infants are commonly born of consanguineous parents [41] . As with factor XI deficiency, plasma levels of the deficient factor do not necessarily correlate with the degree of bleeding diathesis; thus, both of these abnormalities can cause considerable difficulty when deciding how important these deficiencies are in potential abuse cases.
Factor XIII deficiency
Factor XIII deficiency is an extremely rare autosomal recessive bleeding disorder that usually manifests in infancy or early childhood, and the parents are often related. Normal values for standard coagulation screening tests are found. Heterozygotes are not usually symptomatic, but homozygotes have factor XIII levels less than 10% of normal. There is usually a history of umbilical stump bleeding and delayed cord separation, and particular care must be taken to question this [31, 32] . Spontaneous intracranial haemorrhage [33, 42, 43] , persistently defective wound healing, frequent haematomas, and recurrent miscarriage [32] can also occur. A detailed family history is necessary for accurate diagnosis, and screening of families in which index cases have been found helps to identify previously unrecognized cases [42] . function are commonly seen in medical practice [6, 44, 45] . The bleeding diathesis associated with platelet defects usually includes mucocutaneous bleeding, epistaxis, skin purpura, bruising, and excessive haemorrhage following trauma or surgery. Diagnostic tools for the detection of platelet disorders remain relatively limited, and are associated with problems of sensitivity and specificity. First-line tests include the FBC and blood film to examine platelet morphology, and disorders of platelet production may require a bone marrow examination to confirm the presence or absence of megakaryocytes. A normal FBC and coagulation screen do not exclude platelet dysfunction disorders, such as Glanzmann's thrombasthenia (GT) and platelet storage pool defects, although BSS may be suspected when macro-thrombocytopaenia is found on the blood count and film. 'Screening' tests that have been used for platelet dysfunction include the bleeding time [46] , but there is now a wide belief that it is insensitive, inaccurate, unpredictable, and non-reproducible [47] . Furthermore, the bleeding time is difficult to perform, standardize, and interpret when used in children [48] .
Investigation of platelet disorders in children
Unfortunately, the 'gold-standard' investigations remain platelet aggregation and assessment of platelet nucleotides. These are generally only performed in large, well-equipped coagulation laboratories, and are time consuming and technically challenging. In addition, they require a minimum of 15-20 ml whole blood, which can be difficult to obtain in small infants. The other disadvantage is that platelet aggregation tests are often apparently abnormal in the first year or so of life, and this may lead to uncertainty in cases of possible abuse where clarification can only be attained by repeat testing at a later date. It is likely that the reason for this apparent abnormality is due to poorly validated reference ranges in the ,1-year-old age group when it is ethically difficult to establish 'normal' ranges. Flow cytometry using anti-glycoprotein Ib/IX or IIb/IIIa antibodies on small volumes of blood is an important adjunctive test that can confirm GT or BSS; however, normal practice is to confirm the platelet dysfunction associated with these conditions using platelet aggregation, as the glycoprotein may be present but dysfunctional.
The Platelet Function Analyzer
The Platelet Function Analyzer PFA-100 1 (Dade Behring Inc., Deerfield, Illinois, USA) is one of a range of devices that can be used to assess platelet function, and several studies have shown it to be a more effective screening test than the bleeding time [48] [49] [50] [51] . The PFA-100 1 assesses the in vivo response of platelets to vascular injury using a collagen-impregnated membrane coated with either epinephrine or adenosine diphosphate. The technique is ex vivo, but the results can be extrapolated to predict the in vivo situation. The pa-tient's citrated blood is aspirated at high shear rates through an aperture in the collagen-impregnated membrane, and the platelets adhere, aggregate, and form a haemostatic plug that seals the aperture [19] . The time taken to do this is known as the 'closure time'.
Despite the growing use and reported success of the PFA-100 1 , our experience does not support its use as an effective screening procedure for all platelet disorders in children. In a recent study conducted by our group, blood from children with possible and known disorders affecting platelet function (including vWD, Hermansky-Pudlak syndrome, storage pool or release defects, GT, BSS, and Wiskott-Aldrich syndrome) was screened using the PFA-100 1 (see Fig. 1 ). We compared the results with the 'normal range' assessed using normal adults, and segregated results into those children with no apparent haemostatic defect, even on extensive testing, and those with defined disorders. As shown in Figure 1 , screening using both the collagen/ epinephrine and collagen/adenosine diphosphate membranes indicated that many patients with confirmed platelet abnormalities had closure times within the normal range, and young children with no defined clotting defect and no persistent bleeding diathesis frequently provided an abnormal result. Thus, our results suggest that the PFA-100 1 is not a particularly sensitive tool for the detection of non-severe platelet dysfunction, and question the validity of its use as a screening procedure in all children with possible haemostatic defects. The PFA-100 1 is, however, a useful device for excluding very severe platelet function disorders (such as GT) in small infants who have presented with unusual bleeding; in such circumstances, platelet aggregation can be technically difficult due to the large volumes of blood required.
Practical guide for the diagnosis of platelet disorders in children
In our clinic, we have examined several ways in which platelet function can be determined accurately and reliably in children. Rather than relying on the results of the PFA-100 1 screening tests (which are really only useful in ruling out GT), we suggest that additional methods should be applied to ensure accurate diagnosis. Platelet aggregation and platelet nucleotide assessments remain useful in most cases, as does the use of flow cytometry. Although we do not yet use electron microscopy on a routine basis, the utility of this method for the identification and classification of inherited platelet disorders continues to gain credence [52] . Finally, research continues into the molecular diagnosis of platelet dysfunction, and it is hoped that the results of these efforts will provide haematologists with a new and accurate tool for the detection of such disorders.
Conclusions
The investigation of easy bruising and bleeding in children can be extremely difficult, not least because many tests and methods used to evaluate the coagulation system are based on information and values derived from adult samples. Many cases also present with an incomplete family history, leaving the haematologist with little idea of the patient's background or bleeding propensity. In addition, artefact is extremely common when testing children due to the difficulty in obtaining good quality samples, and many frequently used screening tests are of little, if any, value in the accurate assessment of coagulation. For instance, when assessing platelet function, it must be remembered that standard screening tests such as the PFA-100 1 are not sufficient to diagnose or exclude all platelet disorders, Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited. and further investigations should be undertaken before conclusions are drawn. Finally, recognition of the differences between the infant, child, and adult haemostatic systems is essential for accurate diagnosis and appropriate therapeutic intervention.
Despite the difficulties in evaluating those injuries that are suspected to be non-accidental, it is crucial to eliminate coagulation factor deficiencies (including factor XI and factor XIII), vWD, platelet disorders (including thrombocytopenia and leukaemia), and rare conditions such as AE2-antiplasmin deficiency. The tests to eliminate these conditions alone incur considerable expense and do not include measures to eliminate other potentially relevant disorders, such as plasminogen activator inhibitor-1 or vitamin C deficiencies.
The haematologist's responsibility in a court of law involving suspected child abuse is a clear and vital one: to provide the evidence required by the court so that an accurate diagnosis of haemostatic dysfunction or non-accidental injury, or both, can be established. The expert does not represent either side in the case. As many important judgements rely on information provided by the haematologist, it is essential that this role is fulfilled as well as current methods and investigative techniques allow. It is not for the haematologist to make prejudiced judgements; for instance, it is not the haematologist's role to decide that testing for rare, severe abnormalities is unnecessary if such conditions are not detected by screening tests. Similarly, it is not for the haematologist to decide that looking for relatively common minor abnormalities is of no relevance.
It is our earnest wish that national guidelines will be produced very soon stating the parameters to be tested and in which circumstances. It will be vital that this guidance is produced in concordance with the other available expert evidence, in a comprehensive and rational approach to the management of such investigations.
